Mikrochem

Mikrochem is a private equity project in PEZINOK, SK, focused on the production of pure and speciality chemicals, active pharmaceutical ingredients (APIs), medicines and pharmaceutical raw materials. Sympatia invested in the Mikrochem Group companies at the beginning of 2019. The project value at completion is 9 000 000 EUR. The company has its own production and storage facilities in Pezinok and its customers include leading pharmaceutical companies in European and global markets.

The company was founded by its founder and executive director, RNDr. Juraj Čech, in 1990 after several years working at the Chemical Plants of Juraj Dimitrov, today known as Istrochem Group. Production includes pure and speciality chemicals, active pharmaceutical ingredients (APIs) used in medicines, liquid non-sterile medicines for internal and external use, pharmaceutical raw materials, industrial and technical chemicals, as well as specialised molecular distillations and syntheses according to customer requirements.

The group also includes Mikrochem Trade and Mikrochem Energy. Mikrochem Trade focuses on chemical products for laboratory and industrial use, food-grade products, laboratory equipment and specialised measuring devices. Mikrochem Energy operates a cogeneration source producing electricity and heat for the company’s own production process.

Mikrochem is building its further development on expanding its API portfolio and increasing sales of existing products, particularly Methylene Blue and D-mannose. Sympatia sees potential in the production of pure and speciality chemicals, active pharmaceutical ingredients and medicines, as well as in the growing demand for high-quality pharmaceutical raw materials.

This project is implemented within the investment product Polaris Alpha Fund – a qualified investor fund. More information about investment options can be found on the product page.